Global Computer-Aided Drug Discovery (CADD) Services Market Research Report 2023

Publication ID:

PB503231713

Publication Date:

March 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Computer-Aided Drug Discovery is an effective strategy for accelerating and economizing drug discovery and development process. Because of the dramatic increase in the availability of biological macromolecule and small molecule information, the applicability of computational drug discovery has been extended and broadly applied to nearly every stage in the drug discovery and development workflow, including target identification and validation, lead discovery and optimization and preclinical tests. Over the past decades, computational drug discovery methods such as molecular docking, pharmacophore modeling and mapping, de novo design, molecular similarity calculation and sequence-based virtual screening have been greatly improved
Highlights
The global Computer-Aided Drug Discovery (CADD) Services market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Computer-Aided Drug Discovery (CADD) Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Computer-Aided Drug Discovery (CADD) Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Computer-Aided Drug Discovery (CADD) Services in Pharmaceutical or Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Computer-Aided Drug Discovery (CADD) Services include AMRI, Charles River, 厂肠丑谤枚诲颈苍驳别谤, Evotec, Bayers, GVK Biosciences, AstraZeneca, BioDuro and BOC Sciences, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-Aided Drug Discovery (CADD) Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-Aided Drug Discovery (CADD) Services.
The Computer-Aided Drug Discovery (CADD) Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Computer-Aided Drug Discovery (CADD) Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Computer-Aided Drug Discovery (CADD) Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AMRI
Charles River
厂肠丑谤枚诲颈苍驳别谤
Evotec
Bayers
GVK Biosciences
AstraZeneca
BioDuro
BOC Sciences
Aris Pharmaceuticals
ChemDiv
RTI International
XRQTC
Pharmaron
Segment by Type
Virtual Screening
Molecular Docking
Molecular Modeling
Scaffold Hopping
Others
Segment by Application
Pharmaceutical or Biotechnology Companies
Academic or Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Computer-Aided Drug Discovery (CADD) Services companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Computer-Aided Drug Discovery (CADD) Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Virtual Screening
1.2.3 Molecular Docking
1.2.4 Molecular Modeling
1.2.5 Scaffold Hopping
1.2.6 Others
1.3 Market by Application
1.3.1 Global Computer-Aided Drug Discovery (CADD) Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical or Biotechnology Companies
1.3.3 Academic or Research Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Computer-Aided Drug Discovery (CADD) Services Market Perspective (2018-2029)
2.2 Computer-Aided Drug Discovery (CADD) Services Growth Trends by Region
2.2.1 Global Computer-Aided Drug Discovery (CADD) Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Computer-Aided Drug Discovery (CADD) Services Historic Market Size by Region (2018-2023)
2.2.3 Computer-Aided Drug Discovery (CADD) Services Forecasted Market Size by Region (2024-2029)
2.3 Computer-Aided Drug Discovery (CADD) Services Market Dynamics
2.3.1 Computer-Aided Drug Discovery (CADD) Services Industry Trends
2.3.2 Computer-Aided Drug Discovery (CADD) Services Market Drivers
2.3.3 Computer-Aided Drug Discovery (CADD) Services Market Challenges
2.3.4 Computer-Aided Drug Discovery (CADD) Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Computer-Aided Drug Discovery (CADD) Services Players by Revenue
3.1.1 Global Top Computer-Aided Drug Discovery (CADD) Services Players by Revenue (2018-2023)
3.1.2 Global Computer-Aided Drug Discovery (CADD) Services Revenue Market Share by Players (2018-2023)
3.2 Global Computer-Aided Drug Discovery (CADD) Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Computer-Aided Drug Discovery (CADD) Services Revenue
3.4 Global Computer-Aided Drug Discovery (CADD) Services Market Concentration Ratio
3.4.1 Global Computer-Aided Drug Discovery (CADD) Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Computer-Aided Drug Discovery (CADD) Services Revenue in 2022
3.5 Computer-Aided Drug Discovery (CADD) Services Key Players Head office and Area Served
3.6 Key Players Computer-Aided Drug Discovery (CADD) Services Product Solution and Service
3.7 Date of Enter into Computer-Aided Drug Discovery (CADD) Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Computer-Aided Drug Discovery (CADD) Services Breakdown Data by Type
4.1 Global Computer-Aided Drug Discovery (CADD) Services Historic Market Size by Type (2018-2023)
4.2 Global Computer-Aided Drug Discovery (CADD) Services Forecasted Market Size by Type (2024-2029)
5 Computer-Aided Drug Discovery (CADD) Services Breakdown Data by Application
5.1 Global Computer-Aided Drug Discovery (CADD) Services Historic Market Size by Application (2018-2023)
5.2 Global Computer-Aided Drug Discovery (CADD) Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Computer-Aided Drug Discovery (CADD) Services Market Size (2018-2029)
6.2 North America Computer-Aided Drug Discovery (CADD) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2018-2023)
6.4 North America Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Computer-Aided Drug Discovery (CADD) Services Market Size (2018-2029)
7.2 Europe Computer-Aided Drug Discovery (CADD) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2018-2023)
7.4 Europe Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Computer-Aided Drug Discovery (CADD) Services Market Size (2018-2029)
8.2 Asia-Pacific Computer-Aided Drug Discovery (CADD) Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Computer-Aided Drug Discovery (CADD) Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Computer-Aided Drug Discovery (CADD) Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Computer-Aided Drug Discovery (CADD) Services Market Size (2018-2029)
9.2 Latin America Computer-Aided Drug Discovery (CADD) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2018-2023)
9.4 Latin America Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Computer-Aided Drug Discovery (CADD) Services Market Size (2018-2029)
10.2 Middle East & Africa Computer-Aided Drug Discovery (CADD) Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Computer-Aided Drug Discovery (CADD) Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMRI
11.1.1 AMRI Company Detail
11.1.2 AMRI Business Overview
11.1.3 AMRI Computer-Aided Drug Discovery (CADD) Services Introduction
11.1.4 AMRI Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.1.5 AMRI Recent Development
11.2 Charles River
11.2.1 Charles River Company Detail
11.2.2 Charles River Business Overview
11.2.3 Charles River Computer-Aided Drug Discovery (CADD) Services Introduction
11.2.4 Charles River Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.2.5 Charles River Recent Development
11.3 厂肠丑谤枚诲颈苍驳别谤
11.3.1 厂肠丑谤枚诲颈苍驳别谤 Company Detail
11.3.2 厂肠丑谤枚诲颈苍驳别谤 Business Overview
11.3.3 厂肠丑谤枚诲颈苍驳别谤 Computer-Aided Drug Discovery (CADD) Services Introduction
11.3.4 厂肠丑谤枚诲颈苍驳别谤 Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.3.5 厂肠丑谤枚诲颈苍驳别谤 Recent Development
11.4 Evotec
11.4.1 Evotec Company Detail
11.4.2 Evotec Business Overview
11.4.3 Evotec Computer-Aided Drug Discovery (CADD) Services Introduction
11.4.4 Evotec Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.4.5 Evotec Recent Development
11.5 Bayers
11.5.1 Bayers Company Detail
11.5.2 Bayers Business Overview
11.5.3 Bayers Computer-Aided Drug Discovery (CADD) Services Introduction
11.5.4 Bayers Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.5.5 Bayers Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Detail
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Computer-Aided Drug Discovery (CADD) Services Introduction
11.6.4 GVK Biosciences Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.6.5 GVK Biosciences Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Computer-Aided Drug Discovery (CADD) Services Introduction
11.7.4 AstraZeneca Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 BioDuro
11.8.1 BioDuro Company Detail
11.8.2 BioDuro Business Overview
11.8.3 BioDuro Computer-Aided Drug Discovery (CADD) Services Introduction
11.8.4 BioDuro Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.8.5 BioDuro Recent Development
11.9 BOC Sciences
11.9.1 BOC Sciences Company Detail
11.9.2 BOC Sciences Business Overview
11.9.3 BOC Sciences Computer-Aided Drug Discovery (CADD) Services Introduction
11.9.4 BOC Sciences Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.9.5 BOC Sciences Recent Development
11.10 Aris Pharmaceuticals
11.10.1 Aris Pharmaceuticals Company Detail
11.10.2 Aris Pharmaceuticals Business Overview
11.10.3 Aris Pharmaceuticals Computer-Aided Drug Discovery (CADD) Services Introduction
11.10.4 Aris Pharmaceuticals Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.10.5 Aris Pharmaceuticals Recent Development
11.11 ChemDiv
11.11.1 ChemDiv Company Detail
11.11.2 ChemDiv Business Overview
11.11.3 ChemDiv Computer-Aided Drug Discovery (CADD) Services Introduction
11.11.4 ChemDiv Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.11.5 ChemDiv Recent Development
11.12 RTI International
11.12.1 RTI International Company Detail
11.12.2 RTI International Business Overview
11.12.3 RTI International Computer-Aided Drug Discovery (CADD) Services Introduction
11.12.4 RTI International Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.12.5 RTI International Recent Development
11.13 XRQTC
11.13.1 XRQTC Company Detail
11.13.2 XRQTC Business Overview
11.13.3 XRQTC Computer-Aided Drug Discovery (CADD) Services Introduction
11.13.4 XRQTC Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.13.5 XRQTC Recent Development
11.14 Pharmaron
11.14.1 Pharmaron Company Detail
11.14.2 Pharmaron Business Overview
11.14.3 Pharmaron Computer-Aided Drug Discovery (CADD) Services Introduction
11.14.4 Pharmaron Revenue in Computer-Aided Drug Discovery (CADD) Services Business (2018-2023)
11.14.5 Pharmaron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

AMRI
Charles River
厂肠丑谤枚诲颈苍驳别谤
Evotec
Bayers
GVK Biosciences
AstraZeneca
BioDuro
BOC Sciences
Aris Pharmaceuticals
ChemDiv
RTI International
XRQTC
Pharmaron

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂